Intelicanna Ltd Total Assets

Latest as of September 2023: ILA63.16 Billion ILA ≈ $169.34 Million USD

Intelicanna Ltd total assets. Based on the latest financial reports, Intelicanna Ltd (INTL) holds total assets worth ILA63.16 Billion ILA (≈ $169.34 Million USD) as of September 2023. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see INTL stock market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Intelicanna Ltd (2012–2022)

Total assets of Intelicanna Ltd from 2012 to 2022. This chart illustrates how Intelicanna Ltd's total assets have evolved over time, based on quarterly financial data. See Intelicanna Ltd (INTL) stock price for real-time trading data and today's change.

Intelicanna Ltd - Asset Composition Analysis

Intelicanna Ltd Total Assets Breakdown (December 2022)

Intelicanna Ltd total assets breakdown as of December 2022. Intelicanna Ltd's total assets of ILA63.16 Billion consist of 3.3% current assets and 96.7% non-current assets.

Asset Category Amount (ILA) % of Total Assets
Cash & Equivalents ILA0.00 3.3%
Accounts Receivable ILA0.00 0.0%
Inventory ILA0.00 0.0%
Property, Plant & Equipment ILA0.00 0.0%
Intangible Assets ILA558.94 Million 0.9%
Goodwill ILA202.90 Million 0.3%

Asset Composition Trend (2012–2022)

This chart illustrates how Intelicanna Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Intelicanna Ltd short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Intelicanna Ltd's current assets represent 3.3% of total assets in 2022, a decrease from 19.2% in 2012.
  • Cash Position: Cash and equivalents constituted 3.3% of total assets in 2022, down from 19.2% in 2012.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2012.
  • Asset Diversification: The largest asset category is intangible assets at 0.9% of total assets.

Intelicanna Ltd Competitors by Total Assets

Key competitors of Intelicanna Ltd based on total assets are shown below.

Company Country Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Germany €1.60 Trillion
Changchun High & New Technology Industries Group Inc
SHE:000661
China CN¥30.77 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
China CN¥9.94 Billion
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
China CN¥13.81 Billion
Shenzhen Chipscreen Biosciences Co
SHG:688321
China CN¥3.63 Billion
Cronos Group Inc
TO:CRON
Canada CA$1.18 Billion
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
China CN¥6.74 Billion
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829
China CN¥7.35 Billion

Intelicanna Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 22.02 16.67 31.51
Quick Ratio 22.02 16.67 31.51
Cash Ratio 0.00 0.00 0.00
Working Capital ILA8.33 Billion ILA4.30 Billion ILA5.93 Billion

Intelicanna Ltd - Advanced Valuation Insights

This section examines the relationship between Intelicanna Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio -
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 1.4%
Total Assets ILA62.21 Billion
Market Capitalization $5.41 Million USD

Valuation Analysis

Below Book Valuation: The market values Intelicanna Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Intelicanna Ltd's assets grew by 1.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Intelicanna Ltd (2012–2022)

The table below shows the annual total assets of Intelicanna Ltd from 2012 to 2022.

Year Total Assets Change
2022-12-31 ILA62.21 Billion
≈ $166.78 Million
+1.36%
2021-12-31 ILA61.37 Billion
≈ $164.54 Million
-6.57%
2020-12-31 ILA65.69 Billion
≈ $176.11 Million
+15.86%
2019-12-31 ILA56.70 Billion
≈ $152.01 Million
+7.92%
2018-12-31 ILA52.54 Billion
≈ $140.85 Million
-0.18%
2017-12-31 ILA52.63 Billion
≈ $141.10 Million
+12.94%
2016-12-31 ILA46.60 Billion
≈ $124.93 Million
+2.08%
2015-12-31 ILA45.65 Billion
≈ $122.38 Million
+1.16%
2014-12-31 ILA45.13 Billion
≈ $120.98 Million
+10.58%
2013-12-31 ILA40.81 Billion
≈ $109.40 Million
+0.14%
2012-12-31 ILA40.75 Billion
≈ $109.25 Million
--

About Intelicanna Ltd

TA:INTL Israel Drug Manufacturers - Specialty & Generic
Market Cap
$5.41 Million
ILA2.02 Billion ILA
Market Cap Rank
#28327 Global
#406 in Israel
Share Price
ILA43.00
Change (1 day)
-2.49%
52-Week Range
ILA42.90 - ILA114.90
All Time High
ILA11460.00
About

Intelicanna Ltd operates as pharmaceutical company in Israel. It grows, cultivates, produces, research, markets, and sells medical cannabis. The company was formerly known as Tefen Industrial Engineering & Management & Systems Analysis and changed its name to Intelicanna Ltd in March 2019. The company was founded in 1981 and is headquartered in Hod Hasharon, Israel.